|
Market Closed -
Bombay S.E.
03:32:20 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3,106.10 INR | +1.23% |
|
+7.12% | +25.70% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 3,081 | -0.81% | 4 | ||||||
| 1,315.04 | +11.96% | 29 | ||||||
| 272.5 | +1.66% | 22 | ||||||
| 276.59 | +8.26% | 29 | ||||||
| 370.31 | +3.24% | 18 | ||||||
| 154.32 | +0.76% | 21 | ||||||
| 212.66 | +31.03% | 22 | ||||||
| 388.48 | -10.16% | 29 | ||||||
| 309.73 | +4.82% | 23 | ||||||
| 157.41 | +8.05% | 27 | ||||||
| 28.61 | +2.31% | 26 | ||||||
| 563.12 | +3.96% | 25 | ||||||
| 66.21 | -0.56% | 24 | ||||||
| 94.28 | +22.04% | 23 | ||||||
| 21.69 | +17.01% | 20 | ||||||
| 9,350 | +32.94% | 15 | ||||||
| 6,515.81 | +12.34% | 16 | ||||||
| 57.39 | +17.91% | 18 | ||||||
| 71.74 | +51.6% | 17 | ||||||
| 4.214 | +14.45% | 17 | ||||||
| Average | 1,165.55 | +11.64% | 21 | ||||||
| Weighted average by Cap. | 713.73 | +8.42% | 24 |
Select your edition
All financial news and data tailored to specific country editions
